X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (68) 68
index medicus (63) 63
humans (52) 52
lung neoplasms - drug therapy (33) 33
mutation (29) 29
crizotinib (27) 27
female (26) 26
lung neoplasms - genetics (26) 26
respiratory system (25) 25
chemotherapy (24) 24
carcinoma, non-small-cell lung - drug therapy (23) 23
lung cancer (22) 22
article (21) 21
carcinoma, non-small-cell lung - genetics (21) 21
middle aged (20) 20
open-label (20) 20
adult (19) 19
alk (19) 19
male (18) 18
aged (17) 17
cell lung-cancer (17) 17
lung neoplasms - pathology (17) 17
anaplastic lymphoma kinase (16) 16
nivolumab (16) 16
receptor protein-tyrosine kinases - genetics (16) 16
ceritinib (15) 15
docetaxel (14) 14
resistance (14) 14
adenocarcinoma (13) 13
protein kinase inhibitors - therapeutic use (13) 13
carcinoma, non-small-cell lung - pathology (12) 12
nsclc (12) 12
aged, 80 and over (11) 11
lung neoplasms - metabolism (11) 11
tumors (11) 11
alectinib (10) 10
brain metastases (10) 10
cancer (10) 10
immunotherapy (10) 10
non-small cell lung cancer (10) 10
pembrolizumab (10) 10
cell line, tumor (9) 9
gefitinib (9) 9
hemic and lymphatic diseases (9) 9
mutations (9) 9
pyridines - therapeutic use (9) 9
safety (9) 9
treatment outcome (9) 9
antineoplastic agents - pharmacology (8) 8
egfr (8) 8
pyrazoles - therapeutic use (8) 8
receptor protein-tyrosine kinases - antagonists & inhibitors (8) 8
retrospective studies (8) 8
abridged index medicus (7) 7
acquired-resistance (7) 7
animals (7) 7
cancer therapies (7) 7
carcinoma, non-small-cell lung - metabolism (7) 7
care and treatment (7) 7
drug resistance (7) 7
medical research (7) 7
prognosis (7) 7
protein kinase inhibitors - pharmacology (7) 7
acquired resistance (6) 6
brain neoplasms - secondary (6) 6
drug resistance, neoplasm - genetics (6) 6
gene (6) 6
identification (6) 6
inhibitor (6) 6
lung cancer, non-small cell (6) 6
melanoma (6) 6
metastasis (6) 6
mice (6) 6
molecular targeted therapy (6) 6
multicenter (6) 6
proto-oncogene proteins - genetics (6) 6
ros1 (6) 6
young adult (6) 6
activation (5) 5
antineoplastic agents - therapeutic use (5) 5
blockade (5) 5
carcinoma, non-small-cell lung - enzymology (5) 5
crizotinib resistance (5) 5
drug resistance, neoplasm (5) 5
drug therapy (5) 5
eml4-alk (5) 5
erbb receptors - genetics (5) 5
health aspects (5) 5
ipilimumab (5) 5
kinases (5) 5
lung neoplasms - enzymology (5) 5
lung neoplasms - mortality (5) 5
neoplasm staging (5) 5
non–small cell lung cancer (5) 5
receptor protein-tyrosine kinases - metabolism (5) 5
therapy (5) 5
adenocarcinoma - drug therapy (4) 4
advanced melanoma (4) 4
adverse events (4) 4
brain neoplasms - drug therapy (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 08/2019
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 438 - 439
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 3 - 4
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)31074-7 Byline: Justin F Gainor (a), Alice T Shaw (a)... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PROGRESSION-FREE | OPEN-LABEL | CERITINIB | CHEMOTHERAPY | Protein Kinase Inhibitors | Carcinoma, Non-Small-Cell Lung | Pyrazoles | Lung Neoplasms | Humans | Piperidines | Lung cancer | Studies | Chemotherapy | Oncology | Metastasis | Cancer therapies | Drug dosages | Cancer | Pharmaceuticals
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2241 - 2243
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 17, pp. 1658 - 1669
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 07/2019
Resistance to ALK tyrosine kinase inhibitors (TKIs) is often driven by mutations. Here we investigated utility of plasma genotyping for identifying resistance... 
Journal Article
The Oncologist, ISSN 1083-7159, 07/2017, Volume 22, Issue 7, pp. 759 - 761
ALK rearrangements have emerged as important therapeutic targets in oncology. This commentary, in light of recently reported cases, discusses the emerging role... 
CELL LUNG-CANCER | ANAPLASTIC LYMPHOMA KINASE | DABRAFENIB | MEK INHIBITION | ONCOLOGY | COLORECTAL-CANCER | TRAMETINIB | CRIZOTINIB | OPEN-LABEL | IDENTIFICATION | COMBINED BRAF | Commentaries
Journal Article
IMMUNOTHERAPY, ISSN 1750-743X, 06/2019, Volume 11, Issue 8, pp. 647 - 650
Importantly, this study demonstrated that immunotherapy has the potential to provide beneficial effects in patients with advanced melanoma independent of age.... 
EFFICACY | ADULTS | melanoma | COMPREHENSIVE GERIATRIC ASSESSMENT | immune checkpoint inhibitors | IMMUNOLOGY | chemotherapy | YOUNGER | BREAST-CANCER | OLDER PATIENTS | immunotherapy | ELDERLY-PATIENTS | PD-1 | age | Toxicity | Decision making | Melanoma | Systematic review | Arthritis | Cancer therapies | Quality of life | Studies | Cost-benefit analysis | Side effects | Immune checkpoint | Immunotherapy | Age
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 10040 - 10040
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 8532 - 8532
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 08/2017, Volume 125, Issue 8, pp. 591 - 593
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 9079 - 9079
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9093 - 9093
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.